Activ Surgical™, a Boston, Massachusetts-based digital surgery pioneer, raised $45 million in a Series B financing round led by Cota Capital, a multi-stage investment firm focused on private and public modern enterprise technology companies.
Seven new investors, including BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision, and NVIDIA, join existing investors DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV), and ARTIS Ventures to close out the Series B round of financing. To date, Activ Surgical has raised a total of $77 million.
The company will use this Series B financing round to support the commercial availability of the ActivInsights software suite, including the first Insight--an AR-based overlay that displays tissue perfusion in real-time without the use of traditional dyes.
Company: Activ Surgical, Inc.
Round: Series B
Funding Month: September 2021
Lead Investors: Cota Capital
Additional Investors: BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision, NVIDIA, DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV), and ARTIS Ventures
Company Website: https://www.activsurgical.com/
Software Category: surgical software platform>AI
About the Company: Activ Surgical is the pioneering digital surgery company that completed the world’s first autonomous robotic surgery of soft tissue in 2018. The company is revolutionizing surgical vision, enabling a future of augmented reality-based and artificial intelligence-driven surgery that is safe, smart, and accessible to all. Its patent-protected surgical software platform--ActiveEdge™--is being designed to reduce unintended and preventable surgical errors by enhancing a surgeon’s intraoperative decision-making via the aggregation of surgical data from around the world. Activ Surgical is building a hardware-agnostic platform, including the recently announced ActivInsights™ augmented reality (AR)-based software suite, to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence (AI), machine learning (ML), AR, and robotics.